Nonlinear association between standardized uptake value (SUV) index based on <sup>18</sup>F-fluorodeoxyglucose (<sup>18</sup>F-FDG) positron emission tomography/computed tomography (PET/CT) and the new International Association for the Study of Lung Cancer (IASLC) grading of lung invasive non-mucinous adenocarcinoma. [PDF]
Feng J +8 more
europepmc +1 more source
<sup>18</sup>F-Fluorodeoxyglucose positron emission tomography for detection of acute cellular rejection after heart transplantation: A single-center retrospective study. [PDF]
Yoshitake T +15 more
europepmc +1 more source
Host Serum Biomarker Signatures in Mycobacteriologically Cured Pulmonary Tuberculosis Patients with Persistent Lung Inflammation on 18F-FDG PET/CT. [PDF]
Motaung B +12 more
europepmc +1 more source
Potential of Lean Body Mass <sup>18</sup>F-FDG PET/CT Parameters to Predict Pathologic Findings in Overweight Endometrial Cancer Cases. [PDF]
Avcı F +6 more
europepmc +1 more source
The correlation between FDG-PET metabolic parameters, PD-L1 expression and p16/HPV status in oropharyngeal cancers. [PDF]
Horváth A +10 more
europepmc +1 more source
Prognostic role of interim F-18 fluorodeoxyglucose positron emission tomography-computed tomography during chemoradiation therapy in patients with hypopharyngeal squamous cell carcinoma. [PDF]
Mase T +11 more
europepmc +1 more source
Systematic review and meta-analysis of PET-based prognostic metrics in CAR-T treatment of DLBCL. [PDF]
Long C +6 more
europepmc +1 more source
Diagnostic Value of 18F-FDG PET/CT Parameters Combined with Serum FOXM1 for Lymph Node Metastasis in Colorectal Cancer. [PDF]
Zhu Y, Bo L, Li L, Sun Y, Wu B.
europepmc +1 more source
Exploration of the mechanism of the Mongolian medicine Tonglaga-5 (-5) for the treatment of n-methyl-n'-nitro-n-nitrosoguanidine-induced chronic atrophic gastritis based on network pharmacology and metabolomics. [PDF]
Ziqi C +10 more
europepmc +1 more source
Metabolic tumor volume on <sup>18</sup>F-fluorodeoxyglucose uptake as prognostic marker for osimertinib in patients with non-small cell lung cancer harboring sensitive EGFR mutation. [PDF]
Hashimoto K +6 more
europepmc +1 more source

